Woolcott Orison O, Ader Marilyn, Bergman Richard N
Diabetes and Obesity Research Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048.
Endocr Rev. 2015 Apr;36(2):149-73. doi: 10.1210/er.2014-1063. Epub 2015 Feb 12.
Most of the literature related to high altitude medicine is devoted to the short-term effects of high-altitude exposure on human physiology. However, long-term effects of living at high altitudes may be more important in relation to human disease because more than 400 million people worldwide reside above 1500 m. Interestingly, individuals living at higher altitudes have a lower fasting glycemia and better glucose tolerance compared with those who live near sea level. There is also emerging evidence of the lower prevalence of both obesity and diabetes at higher altitudes. The mechanisms underlying improved glucose control at higher altitudes remain unclear. In this review, we present the most current evidence about glucose homeostasis in residents living above 1500 m and discuss possible mechanisms that could explain the lower fasting glycemia and lower prevalence of obesity and diabetes in this population. Understanding the mechanisms that regulate and maintain the lower fasting glycemia in individuals who live at higher altitudes could lead to new therapeutics for impaired glucose homeostasis.
大多数与高原医学相关的文献都致力于研究高原暴露对人体生理的短期影响。然而,就人类疾病而言,长期生活在高原的影响可能更为重要,因为全球有超过4亿人居住在海拔1500米以上的地区。有趣的是,与生活在海平面附近的人相比,生活在高海拔地区的人空腹血糖水平较低,葡萄糖耐量更好。也有新出现的证据表明,高海拔地区肥胖和糖尿病的患病率较低。高原地区葡萄糖控制改善的潜在机制尚不清楚。在这篇综述中,我们展示了关于生活在海拔1500米以上居民葡萄糖稳态的最新证据,并讨论了可能解释该人群空腹血糖较低以及肥胖和糖尿病患病率较低的机制。了解调节和维持高海拔地区居民较低空腹血糖的机制可能会带来针对葡萄糖稳态受损的新疗法。